Amgen Day 1 Edited Photos-0570Amgen Day 1 Edited Photos-0570
Amgen Day 1 Edited Photos-0947Amgen Day 1 Edited Photos-0947
Amgen Day One-4588Amgen Day One-4588

Pioneering Next Generation Biomanufacturing in Asia: Transforming Manufacturing for Better Patient Outcomes

A pioneer in biomanufacturing, Amgen Singapore Manufacturing is at the forefront of innovation and technology in the industry. Home to Amgen’s first Next-Generation biologics and chemical synthesis manufacturing facilities in Asia, our advanced manufacturing sites play a pivotal role in delivering high-quality, life-saving therapeutics to patients across the globe. A multi-product, award-winning facility, we continuously invest in cutting-edge technologies and our people to expand our global reach and enhance our manufacturing capabilities.

Our state-of-the-art facilities in Singapore combine innovative technologies with sustainable manufacturing processes, reducing our environmental footprint while driving operational efficiencies. These investments ensure a reliable, uninterrupted supply of drug substances for Amgen’s global pipeline, supporting the delivery of life-changing medicines around the world.

With a strong commitment to operational excellence, our Singapore facility consistently meets the highest quality and regulatory standards. This ensures that every product we deliver is safe, effective, and reliable. Our success is driven by a highly skilled workforce and a disciplined approach, enabling us to consistently uphold the quality standards our patients depend on to ensure we serve every patient, every time.

Key Milestones in Our Journey


  • 2014: Heralding the Next-Generation of Biomanufacturing

    Amgen unveiled its pioneering Next-Generation Biomanufacturing facility in Singapore’s Tuas Biomedical Park in 2014. This state-of-the-art plant and Amgen’s first manufacturing site in Asia, integrates multiple innovative technologies into a single facility to achieve greater speed, productivity, and flexibility in commercial-scale manufacturing. Built in half the construction time, at approximately one quarter of the capital cost and half of the operating cost required, the facility boosts a significantly smaller manufacturing footprint and higher environmental efficiencies including reduced consumption of water and energy and lower levels of carbon emissions. Watch and learn more

  • 2015: Expanding Our Manufacturing Capabilities to Serve More Patients

    Amgen expanded Singapore’s manufacturing footprint in 2015 with the opening of its first commercial chemical synthesis manufacturing facility at Tuas Biomedical Park. Producing active pharmaceutical ingredients, this facility further underscores Amgen's commitment to delivering high-quality drug substances and improving patient outcomes globally.

  • 2018: Fostering Innovation and Growth to Support Amgen’s Growth

    Amgen launched its NextGen Workplace, a 7,500-square-meter hub designed to inspire innovation, enhance collaboration, and foster a vibrant work culture. This cutting-edge workspace supports both our manufacturing facilities, providing an environment that promotes productivity and creativity to support Amgen’s continued growth in Singapore.

Advancing Science. Strengthening Healthcare. Empowering Singapore’s Biotech Future.

Amgen is committed to driving innovation in the industry and position Singapore as a global biotech hub. Through strategic investments and partnerships in technology, infrastructure, and talent, we collaborate with stakeholders to fuel growth and progress.

Key initiatives like the Amgen Golden Ticket support this vision, while programs such as Amgen Scholars and the Amgen Biotech Experience supported through the Amgen Foundation, seeks to inspire the next generation of STEM talents, ensuring a future-ready workforce for the biotech sector.

As we expand our presence in Singapore, we continue to invest in continuous learning and industry development to meet the growing healthcare demands in the region, contributing to global health and improving the lives of millions of patients.

Our Differences Lead to Better Science

With more than 350 employees represented across 17 nationalities and four generations, our vibrant, multicultural environment in our Singapore manufacturing site fosters a sense of belonging, where diverse perspectives fuel innovation and progress. Inclusion is at the heart of everything we do—helping us serve patients better, reduce inequities, and create a space where every employee can thrive.

Through our employee-lead Employee Resource Groups (ERGs), we inspire growth, development, and connection, ensuring every voice can contribute to make a difference towards our mission. Learn more about our ERGs.